ArticleEpilepsy currents2026
How to Recognize and Manage Missing Key Electrodes in Defining the Epileptogenic Zone.
Article in Epilepsy currents, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Identifying and localizing the epileptogenic zone (EZ) is the cornerstone of successful epilepsy surgery, as it directly determines surgical efficacy and patient outcomes. Stereoelectroencephalography (SEEG) has emerged as a transformative tool for pinpointing the EZ, offering precise 3-dimensional recordings of seizure activity in individual patients. SEEG does not begin with electrode implantation, but with the formulation of a precise hypothesis regarding the epileptogenic networks involved. This hypothesis is based on data gathered during Phase I investigations, particularly the electroclinical correlations of seizure obtained from video-EEG monitoring. SEEG can be appropriately performed only when a prior estimation of EZ and propagation networks is available. The guiding principle of SEEG is therefore not exhaustive anatomical coverage, but rather the validation of a predefined hypothesis. Consequently, certain brain regions are deliberately not explored, there is always missing electrodes. However, in some cases, we encounter true "missing" electrodes, unanticipated gaps in electrode coverage, that can profoundly impact the diagnostic process. These missing electrodes may create critical gaps in the spatial sampling of epileptic networks, leading to incomplete localization of the EZ. This limitation can hinder the identification of seizure onset zone, propagation pathways, and network interactions, ultimately restricting surgical options and compromising patient outcomes. Current clinical practice highlights a significant knowledge gap in how to anticipate such issues during SEEG planning and how to optimally interpret data when electrode coverage is suboptimal. Key questions remain: How can electrode placement errors be identified early? And how can emerging technologies help compensate for these gaps? In this article, we aim to illustrate and discuss these critical issues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.